TY - JOUR
T1 - Lung Transplantation and Donation After Cardiac Death
T2 - A Single Center Experience
AU - Puri, Varun
AU - Scavuzzo, Masina
AU - Guthrie, Tracey
AU - Hachem, Ramsey
AU - Krupnick, Alexander S.
AU - Kreisel, Daniel
AU - Patterson, G. Alexander
AU - Meyers, Bryan F.
PY - 2009/11
Y1 - 2009/11
N2 - Background: Lung donation after cardiac death (DCD) can enlarge the donor pool. Single-center reports have shown comparable outcomes after lung transplantation using conventional donors versus DCD in small numbers of patients. Methods: We performed a retrospective review of DCD experience at a single lung transplant program using a prospective database. Results: Between January 2003 and April 2008, 293 lung transplantations were performed, including 11 bilateral transplantations (3.7%) using DCD lungs. Similar criteria were used to assess donor quality. The hospital mortality for DCD recipients was 2 of 11 (18%) and overall mortality was 4 of 11 (36%) by 18 months of follow-up. Seven DCD patients (64%) are alive with a median follow-up of 32 months. The DCD group was comparable to the control group in age and ischemic times. The 4 deaths, when compared with 7 DCD survivors, had longer ischemic time (293 minutes versus 232 minutes) and a higher incidence of nonlocal donors (3 of 4 versus 1 of 7). Conclusions: At our center, early outcomes after DCD lung transplantations are somewhat inferior to those of series from other centers but approach national averages for conventional lung transplantation. Thus, DCD lung transplantation has the potential to increase the donor pool but must be offered cautiously.
AB - Background: Lung donation after cardiac death (DCD) can enlarge the donor pool. Single-center reports have shown comparable outcomes after lung transplantation using conventional donors versus DCD in small numbers of patients. Methods: We performed a retrospective review of DCD experience at a single lung transplant program using a prospective database. Results: Between January 2003 and April 2008, 293 lung transplantations were performed, including 11 bilateral transplantations (3.7%) using DCD lungs. Similar criteria were used to assess donor quality. The hospital mortality for DCD recipients was 2 of 11 (18%) and overall mortality was 4 of 11 (36%) by 18 months of follow-up. Seven DCD patients (64%) are alive with a median follow-up of 32 months. The DCD group was comparable to the control group in age and ischemic times. The 4 deaths, when compared with 7 DCD survivors, had longer ischemic time (293 minutes versus 232 minutes) and a higher incidence of nonlocal donors (3 of 4 versus 1 of 7). Conclusions: At our center, early outcomes after DCD lung transplantations are somewhat inferior to those of series from other centers but approach national averages for conventional lung transplantation. Thus, DCD lung transplantation has the potential to increase the donor pool but must be offered cautiously.
UR - http://www.scopus.com/inward/record.url?scp=70449698373&partnerID=8YFLogxK
U2 - 10.1016/j.athoracsur.2009.06.039
DO - 10.1016/j.athoracsur.2009.06.039
M3 - Article
C2 - 19853120
AN - SCOPUS:70449698373
SN - 0003-4975
VL - 88
SP - 1609
EP - 1615
JO - Annals of Thoracic Surgery
JF - Annals of Thoracic Surgery
IS - 5
ER -